ACC and CRF Announce Partnership on American College of Cardiology’s Innovation in Intervention: i2 Summit
May 28, 2008 -- New York and Washington,
DC --
The American College of Cardiology (ACC) and the Cardiovascular Research
Foundation
(CRF) announced today a multi-year partnership to jointly sponsor
the ACC i2 interventional cardiology meeting in Orlando, Fla., March
28–31,
2009, during ACC.09, the ACC’s 58th Annual Scientific Session and the
world’s premier cardiovascular meeting. This will be the beginning
of a five-year partnership committed to collectively developing the
interventional component of the ACC Annual Scientific Session.
The ACC’s Innovation in Intervention:
i2 Summit in partnership with the Cardiovascular Research Foundation
in Orlando will deliver in-depth and cutting-edge science provided
in a forum for both general cardiologists and interventional
specialists, educating and guiding physicians, as well as cardiac
care team members, to the next level of knowledge and practice.
The meeting will emphasize the translation of evidence-based
science and clinical trial data into daily interventional practice.
We are honored to partner with the ACC
to organize and enhance the preeminent interventional cardiology
meeting of the spring,” said Gregg W. Stone, M.D., Chairman of the Cardiovascular Research Foundation and professor of medicine at Columbia University Medical Center/New York-Presbyterian Hospital. “The annual scientific session of the American College of Cardiology represents a unique opportunity to introduce the latest advances in interventional medicine to the greater cardiology community. It is our hope that CRF’s
expertise in cutting edge medical education will help appropriately
translate evidence-based science into clinical practice.”
“ The i2 Summit will offer unsurpassed evidence-based content, presented by leaders in interventional cardiology, and this collaboration brings together the strengths and expertise of both the ACC and CRF to deliver an unparalleled program that appeals to all cardiovascular professionals,” said ACC President Douglas Weaver, M.D. “The ACC is committed to providing more value to attendees at our meeting by having a wide venue of educational opportunities for physicians including state-of-the-art updates, late breaking clinical trials and education required for credentialing and recertification.”
The program committee will assemble a broad-based group of domestic
and international interventional cardiologists and other heart disease
specialists to provide a forum for interventional cardiology experts
to discuss new developments within the field as well as a focused
venue to train, educate and guide their colleagues in intervention
and cardiac care. The program will feature late-breaking clinical
trials, case-based education, and analysis of advances in treating
diseases of the coronary, vascular, and peripheral vessels as well
as pediatric and structural heart disease.
In the coming weeks, additional details about the meeting will be
announced.
About the ACC
The American College of Cardiology is leading the way to optimal
cardiovascular care and disease prevention. The College is a 34,000-member
nonprofit medical society and bestows the credential Fellow of the
American College of Cardiology upon physicians who meet its stringent
qualifications. The College is a leader in the formulation of health
policy, standards and guidelines, and is a staunch supporter of cardiovascular
research. The ACC provides professional education and operates national
registries for the measurement and improvement of quality care.
About CRF
The Cardiovascular Research Foundation is an independent, non-profit academically
focused organization dedicated to improving the survival and quality of life
of patients with cardiovascular disease through research and education. For over
18 years, CRF has played a major role in realizing dramatic improvements in the
lives of patients by establishing the safe use of new technologies and therapies
in the subspecialty of interventional cardiology and endovascular medicine. For
more information, please visit www.crf.org.
Source: American College of Cardiology
and Cardiovascular Research Foundation
(Disclaimer: external
links to news, press releases and other timely information
sources are provided as a service by Angioplasty.Org, which
is not responsible for the content found on any external
sites. Items marked with a ($$) indicate that the external
site normally restricts viewing to paid subscribers. Other
sites may require free registration.